The OIG is reviewing who pays for drugs during Part A stays. See your exposure in 48 hours →

When a nursing home pays for resident medications outside Part A

When a nursing home pays for resident medications outside Part A, money often leaks. Six places long-stay charges land on you, and how to check them.

Get a free 48-hour audit Estimate your savings

Outside a covered Part A stay, a nursing home pays for resident medications far less often than its invoices suggest. For a long-stay resident, the pharmacy should normally bill the resident's Part D plan, Medicaid, the hospice or the resident, and the facility should carry only what its contracts or per-diem obligations put on it. Rejected Part D claims, hospice drugs, Medicaid-pending residents, house stock, Medicare Advantage carve-outs and stale payer flags are where charges drift onto the facility.

During a covered Part A stay the facility owes for the drugs, a rule we cover in who pays for drugs during a Part A stay. This article is about everyone else.

Who should pay for a long-stay resident's medications?

A long-stay resident is a resident who is not in a covered Medicare Part A skilled stay. For these residents, the drug bill normally goes somewhere other than the facility:

  • Medicare Part D, the prescription drug benefit run by private plans, pays for most covered prescription drugs. Part D plans must require their network pharmacies to submit claims to the plan whenever the resident's card is presented or on file (42 CFR 423.120(c)(3)).
  • Medicaid pays for some drugs Part D does not, under state rules.
  • The hospice pays for drugs related to the terminal illness.
  • The resident pays for what no program covers.

The facility does carry some costs outside Part A, such as over-the-counter house stock and drugs its Medicare Advantage contracts put inside the daily rate. But a prescription drug for a long-stay resident with active drug coverage should rarely end up as a facility charge.

For the payer split by drug type, see Part A, Part B or Part D: who pays for each drug.

What could your building recover?

Two numbers, instant estimate. No email needed.

Estimated recoverable per year$0
See your full estimate Planning estimate for one building at 85% occupancy. How it works

Where does a nursing home end up paying for resident medications outside Part A?

Each line looks small. In a mostly long-stay building, they recur monthly across many residents, which is why the total can exceed the Part A piece. Six places account for most of it.

1. Part D rejections passed through as facility bills

A claim rejection is the plan's real-time refusal to pay a pharmacy claim: prior authorization required, drug not on formulary, or refill too soon. Some pharmacies then dispense the drug and send the facility a bill for the rejected Part D claim.

Many rejections are fixable. Part D sponsors must run a transition process, a set of temporary-fill rules for enrollees whose drugs are not on the plan's formulary or need prior authorization or step therapy (42 CFR 423.120(b)(3)). It covers new enrollees, people who switch plans mid-year and current enrollees hit by a formulary change. Plans must ensure access to a temporary supply within the first 90 days of coverage, a timeframe the regulation applies to long-term care pharmacies, and the temporary fill is at least an approved month's supply.

Outside that window, the prescriber can request a formulary exception under 42 CFR 423.578, or the prescriber and consultant pharmacist can choose a covered alternative. A refill-too-soon edit can reflect a dose change or a new admission, and the pharmacy can ask the plan for an override with the reason. The fix belongs with the pharmacy and the prescriber. The cost should not default to you.

Under the hospice conditions of participation, drugs related to the palliation and management of the terminal illness and related conditions, as identified in the hospice plan of care, "must be provided by the hospice" while the patient is under hospice care (42 CFR 418.106). Unrelated drugs follow the resident's normal coverage, usually Part D or Medicaid.

The leak happens when nobody updated the pharmacy's profile after the hospice election, or nobody agreed who supplies what. Whether a drug is related is a clinical determination made by the hospice and the prescriber, with input from the consultant pharmacist. The business office's job is to make sure every hospice resident's drugs have a documented answer and are billed accordingly.

3. Medicaid-pending residents and retroactive eligibility

A Medicaid-pending resident has applied for Medicaid but has not yet been approved. While the application is open, Medicaid-pending pharmacy charges can land on the facility.

Approval can reach backward. Federal rules require states to make Medicaid eligibility effective no later than the third month before the month of application, when the person received covered services and would have been eligible then (42 CFR 435.915). For a full-benefit dual eligible not yet in a drug plan, Medicare's LI NET program, a temporary Part D coverage program, can provide retroactive coverage reaching back as far as 36 months (42 CFR 423.2504).

So charges you paid during the pending period may be rebillable after approval. Retroactive rules and rebilling practice vary by state, so confirm the details with your state Medicaid agency and your pharmacy, then track the credits as described in pharmacy credits and returns.

4. OTC and house stock under the Medicaid per diem

House stock is the supply of common over-the-counter (OTC) items, such as acetaminophen, that a facility keeps for general use instead of dispensing per resident. Federal rules list over-the-counter drugs among the routine items a facility must not charge to a resident's funds during a covered Medicare or Medicaid stay (42 CFR 483.10(f)(11)(i)(E)), so the facility usually pays for them. Whether a state's Medicaid pharmacy benefit covers some prescribed OTC drugs is state-specific.

The check is price and volume: house stock billed at your contract price, in quantities that match what the floors use.

5. Medicare Advantage carve-outs

For Medicare Advantage residents, the facility's contract with the plan decides which drugs sit inside the daily rate. A carved-out drug paid on your invoice and never billed to the plan is a straight loss. We cover the mechanics in Medicare Advantage drug carve-outs.

6. Wrong payer on long-stay days

The pharmacy's billing profile for each resident should mirror your census. When a Part A stay ends, a resident switches Part D plans or picks up Medicaid, the profile needs the new payer that day. A stale flag keeps the facility paying for drugs another payer should cover. Reading your census report for pharmacy billing explains which fields to compare.

What should you check for each charge type?

Charge typeWho should usually payWhat to checkEvidence you need
Part D rejection billed to facilityThe resident's Part D plan, after the rejection is resolvedRejection reason, whether a transition fill or exception was requestedRejection code, prescriber request, plan response
Hospice-related drugThe hospiceHospice election date and the hospice's relatedness decisionHospice election, plan of care, hospice-facility agreement
Drug for a Medicaid-pending residentMedicaid or Part D once approved, often retroactivelyApproval date and effective date of coverageEligibility notice, pharmacy rebill and credit
OTC or house stockUsually the facilityPrice against contract, quantity against usePharmacy services agreement, usage records
Medicare Advantage carved-out drugThe MA plan, per contractWhether the drug is on the carve-out list and authorizedMA contract, authorization, claim to plan
Drug billed on a non-Part A dayPart D, Medicaid, Part B or the residentPayer flag date against censusCensus payer history, invoice line date

How should the business office review non-Part A charges each month?

  1. Pull every facility-billed line for residents not in a Part A stay. Use the invoice detail and the census for the same month.
  2. Sort by reason. Rejections, hospice, Medicaid-pending, house stock, MA residents and unexplained lines.
  3. Ask for the rejection reason on each pass-through. Ask whether a transition fill, exception request or alternative was pursued.
  4. Match hospice residents to election dates. Confirm related drugs are documented and billed to the hospice.
  5. Keep a Medicaid-pending log. Application date, charges fronted, approval date. On approval, request rebilling and track the credit.
  6. Check house stock against the contract. Unit prices and monthly quantities against the agreement and actual use.
  7. Run MA residents through the carve-out matrix. Every carved-out drug should end in a claim to the plan.
  8. Compare the pharmacy's payer flags to census. Any long-stay resident still flagged to the facility needs a correction date.
  9. Dispute in writing within the agreement's window. One list, with evidence. Our guide on how to dispute a pharmacy invoice includes a letter template.

Free · 48 hours · no integration

Get a free 48-hour pharmacy audit

  • Send three files: invoices, census, contract
  • See overbilling and Part A exposure, line by line
  • BAA signed before any data moves

What does one unresolved rejection cost? An illustrative example

The figures below are an illustrative example, not drawn from any client, pharmacy or plan.

A long-stay resident switches Part D plans in January. A maintenance drug needs prior authorization under the new plan, the claim rejects, and the pharmacy bills the facility $9 a day. Nobody requests the transition fill or the authorization. After six months, the facility has paid roughly $1,600 for one resident.

Charges like this are hardest to catch where one person covers census and billing, as in many independent nursing homes, and they multiply for regional operators with several buildings.

This article is general information, not legal or clinical advice. Whether a drug is related to a terminal illness is decided by the hospice and prescriber, with the consultant pharmacist. State Medicaid rules vary. Facilities make their own billing and dispute decisions.

Frequently asked questions

Should a nursing home pay when a Part D plan rejects a resident's claim?

Not by default. Many prior authorization or non-formulary rejections can be resolved through the plan's transition process, an exception request or a covered alternative. Ask the pharmacy for the rejection reason and what was done before accepting the charge.

Who pays for hospice drugs in a nursing home?

The hospice is responsible for drugs related to the palliation and management of the terminal illness and related conditions, as identified in the hospice plan of care. Unrelated drugs follow the resident's usual coverage. The hospice and prescriber decide relatedness.

Who pays for medications while a resident's Medicaid is pending?

The facility may front the cost while the application is open. Federal rules require states to make eligibility effective up to three months before the application month for people who qualified then, and retroactive Part D coverage may also apply. Track what you paid and request rebilling after approval, following your state's rules.

Can a nursing home charge a resident for over-the-counter drugs?

Not during a covered Medicare or Medicaid stay. Federal rules list over-the-counter drugs among routine items a facility must not charge to a resident's personal funds. State Medicaid coverage of prescribed OTC drugs varies.

Get the 48-hour first look

Send three months of pharmacy invoices, your census and your pharmacy services agreement. Within 48 hours we show which facility-billed long-stay lines look like they belong to another payer. Start with the free 48-hour audit or estimate the dollars with the savings calculator.